For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211202:nRSB2991Ua&default-theme=true
RNS Number : 2991U TMT Investments PLC 02 December 2021
02 December 2021
TMT INVESTMENTS PLC
("TMT" or the "Company")
Director/PDMR Shareholding
TMT Investments Plc (AIM: TMT.L), the venture capital company investing in
high-growth technology companies, announces that on 1 December 2021, Alexander
Selegenev, Executive Director of TMT, acquired a total of 3,000 ordinary
shares of no par value each in the Company ("Ordinary Shares") at an average
price of US$7.40 per share.
Following the transaction, Mr Selegenev is interested in 65,812 Ordinary
Shares, representing approximately 0.21% of the Company's issued ordinary
share capital.
The notification below, made in accordance with the requirements of the EU
Market Abuse Regulation, provides further detail in respect of the transaction
as described above.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Alexander Selegenev
2 Reason for the notification
a) Position/status PDMR (Executive Director)
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name TMT Investments Plc
b) LEI 213800UGZLGI4R6YW964
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of no par value each
Identification code JE00B3RQZ289
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
US$7.40 1,500
US$7.40 1,500
d) Aggregated information
- Aggregated volume Purchase of, in aggregate, 3,000 ordinary shares
- Price Average price of purchases of US$7.40
e) Date of the transaction 1 December 2021
f) Place of the transaction London Stock Exchange, AIM (XLON)
For further information contact:
TMT Investments Plc +44 (0)1534 281 800
Alexander Selegenev (Computershare - Company Secretary)
Executive Director
www.tmtinvestments.com (http://www.tmtinvestments.com) alexander.selegenev@tmtinvestments.com
(mailto:alexander.selegenev@tmtinvestments.com)
Strand Hanson Limited +44 (0)20 7409 3494
(Nominated Adviser)
James Bellman / James Dance
Cenkos Securities plc +44 (0)20 7397 8900
(Joint Broker)
Ben Jeynes
Hybridan LLP +44 (0)20 3764 2341
(Joint Broker)
Claire Louise Noyce
Kinlan Communications +44 (0)20 7638 3435
David Hothersall davidh@kinlan.net (mailto:davidh@kinlan.net)
About TMT Investments Plc
TMT Investments Plc invests in high-growth technology companies across a
number of core specialist sectors and has a significant number of Silicon
Valley investments in its portfolio. Founded in 2010, TMT has a current
investment portfolio of over 50 companies and net assets of US$218 million as
of 30 June 2021. The Company's objective is to generate an attractive rate
of return for shareholders, predominantly through capital appreciation. The
Company is traded on the AIM market of the London Stock Exchange.
www.tmtinvestments.com (http://www.tmtinvestments.com) .
Twitter (https://twitter.com/TMT_PLC)
LinkedIn (http://www.linkedin.com/company/tmt-investments-plc)
Facebook (https://www.facebook.com/TmtInvestmentsPlc/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUAOARAAUURUA